Medical treatment of recurrent meningiomas

A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas

(2011) J. J. Raizer et al.   NEURO-ONCOLOGY

A review of malignant meningiomas: diagnosis, characteristics, and treatment

(2010) Simon Hanft et al.   JOURNAL OF NEURO-ONCOLOGY

Aberrant signaling pathways in meningiomas

(2010) Brian T. Ragel et al.   JOURNAL OF NEURO-ONCOLOGY

Epidemiology and etiology of meningioma

(2010) Joseph Wiemels et al.   JOURNAL OF NEURO-ONCOLOGY

Medical therapies for meningiomas

(2010) Patrick Y. Wen et al.   JOURNAL OF NEURO-ONCOLOGY

High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma

(2010) M. C. Chamberlain et al.   NEURO-ONCOLOGY

Genomic Landscape of Meningiomas

(2009) Yohan Lee et al.   BRAIN PATHOLOGY

Advances in meningioma therapy

(2009) Andrew D. Norden et al.   Current Neurology and Neuroscience Reports

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)

(2009) Patrick Y. Wen et al.   NEURO-ONCOLOGY

Interferon-α for recurrent World Health Organization grade 1 intracranial meningiomas

(2008) Marc C. Chamberlain et al.   CANCER